Biomarkers and Therapeutic Drug Monitoring in Psychiatry

The World Health Organization, WHO, reported in 2010 that there were approximately 490 million (7%) of people suffering from mental disorders, such as abuse of alcohol and other substances, major depression, bipolar disorder, schizophrenia and dementia, recommending research the pathophysiology of these disorders in order to improve their understanding and to develop more efficient and cost-effective interventions (WHO 2001, 2005).